Home » Topics » Drug design, drug delivery and technologies, BioWorld Science

Drug design, drug delivery and technologies, BioWorld Science
RSS

Patent protection granted for Hybridon second- and third-generation oligonucleotides

Aug. 6, 1997

Tripos, Panlabs and Amylin reach metabolic drug screening agreement

Aug. 6, 1997

FDA gives AngioDynamics marketing clearance for its Pulse-Spray Injector

Aug. 6, 1997

CombiChem and Sumitomo establish drug discovery collaboration

Aug. 5, 1997

Access and The Dow Chemical Company enter into collaboration

Aug. 4, 1997

Stanford scientists report breakthrough in polyketide research

Aug. 4, 1997

Xoma issued further U.S. patents based on BPI platform

Aug. 1, 1997

Cel-Sci allowed patent for immune system technology

Aug. 1, 1997

Vyrex awarded U.S. patent for CD-Tagging

Aug. 1, 1997

Jenner licenses emulsion formulation from Walter Reed

July 29, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...